{"product_id":"biologics-biosimilars-and-biobetters-9781119564652","title":"Biologics Biosimilars and Biobetters","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eA comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eExplains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about\u003c\/li\u003e \u003cli\u003eGuides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence\u003c\/li\u003e \u003cli\u003eBalances scientific information on complex drugs with practical information, such as a checklist for pharmacists\u003c\/li\u003e \u003c\/ul\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of Contributors vii\u003c\/p\u003e \u003cp\u003eForeword ix\u003c\/p\u003e \u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003e1 Innovator Biologics, Biosimilars, and Biobetters: Terminology, Nomenclature, and Definitions 1\u003c\/p\u003e \u003cp\u003e2 Approved Biologic Medicines and Biosimilars in Major Regulatory Jurisdictions 17\u003c\/p\u003e \u003cp\u003e3 Status of Biologic Drugs in Modern Therapeutics-Targeted Therapies vs. Small Molecule Drugs 31\u003c\/p\u003e \u003cp\u003e4 Major Classes of Biotherapeutics 47\u003c\/p\u003e \u003cp\u003e5 Drug Targets for Biologics 71\u003c\/p\u003e \u003cp\u003e6 Pivotal Biology, Chemistry, Biochemistry, and Biophysical Concepts of Biologics and Biosimilars 89\u003c\/p\u003e \u003cp\u003e7 Biosimilarity and Interchangeability of Biologic Drugs-General Principles, Biophysical Tests, and Clinical Requirements to Demonstrate Biosimilarity 109\u003c\/p\u003e \u003cp\u003e8 Pharmacokinetics of Biologics 125\u003c\/p\u003e \u003cp\u003e9 Pharmacogenomics of Biologics 147\u003c\/p\u003e \u003cp\u003e10 International Regulatory Processes and Policies for Innovator Biologics, Biosimilars, and Biobetters 159\u003c\/p\u003e \u003cp\u003e11 Pharmacovigilance of Innovator Biologics and Biosimilars 177\u003c\/p\u003e \u003cp\u003e12 Pharmacoeconomics of Biologic Medicines and Biosimilars 195\u003c\/p\u003e \u003cp\u003e13 New Emerging Biotherapies: Cutting-Edge Research to Experimental Therapies 213\u003c\/p\u003e \u003cp\u003e14 Optimizing Use of Biologic Medicines Using a Quality Use of Medicines Approach 237\u003c\/p\u003e \u003cp\u003e15 Knowledge Areas and Competency Standards on Biologic Medicines for Pharmacists and Pharmacy Students 253\u003c\/p\u003e \u003cp\u003e16 A Checklist for Pharmacists on Biologics and Biosimilars: Tips to Enhance Patient-Centered Discussions 267\u003c\/p\u003e \u003cp\u003eIndex 295\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49407085183319,"sku":"9781119564652","price":107.96,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119564652.jpg?v=1730498126","url":"https:\/\/bookcurl.com\/products\/biologics-biosimilars-and-biobetters-9781119564652","provider":"Book Curl","version":"1.0","type":"link"}